The Ion

Global Partnerships Make It a Smaller, Healthier World

Tricol Biomedical’s far-reaching hemostatic solutions benefit worldwide healthcare, impacting the approximate 40 percent of trauma-related deaths that result from bleeding and helping to control bleeding in hospitals due to surgery or other clinical procedures. Tricol’s proprietary muco-adhesive chitosan formulation, Chito+™, on its vast portfolio of medical devices, supplies distribution partners with its lifesaving products on Read More »

Fully Stocked so “The Blood Stops Here”—for Patients and Practitioners

In 2022, Tricol Biomedical completed its strongest production year. This is remarkable considering supply chain issues and the lingering pandemic, which continue to cause worldwide disruption. Supply chain leaders in healthcare are using lessons learned during these unprecedented times to ensure a more stable future. Many of their initiatives align with Tricol’s ongoing best practices. Read More »

Tricol’s Hemostatic Devices Have What It Takes, According to ECRI

ECRI, a well-known and trusted voice in healthcare, focused on quality, safety and cost, across the healthcare spectrum, analyzed hemostasis pads. They identified four key considerations to help choose the best. Tricol Biomedical offers two hemostatic devices for vascular closure; the HemCon® Patch Pro, and the HemCon® OneStopTM Vascular. Tricol Biomedical’s Chief Science Officer, Dr. Read More »

Employee Spotlight: Dr. Simon McCarthy

Meet Dr. Simon McCarthy, Science and Technology Fellow at Tricol. This Q&A gives insight into why Simon joined the Tricol team and the important research he is doing in the field of Hemostasis. Q: You are certainly a well-known, respected, and published scientist in the field of Hemostasis, no argument there. How did you first Read More »

Employee Spotlight: MacKayla Carolan

Meet MacKayla Carolan, Research Associate at Tricol. This Q&A gives insight into why MacKayla joined the Tricol team and her involvement with being part of innovative, lifesaving technology. What is your background, and what led to you joining the Tricol team? I got my degree in chemistry from Willamette University in Salem, Oregon, in 2019, Read More »

HemCon Chitosan Hemostatic Devices and the Body’s Clotting Cascade

In our final article of our first of many educational series, we are going to review the body’s natural clotting cascade and how HemCon’s hemostatic devices do not rely on this process to control bleeding.  We often talk about how our products work “outside of the clotting cascade” but what does that really mean? What Read More »

Chitosan’s Anti-Bacterial Properties

It has been over one year since the world was shut down in response to COVID-19. Since then, the general population has become more in tune with proper health and safety practices such as washing hands and wearing masks. Wearing a mask has become an important practice used to prevent respiratory droplets from reaching others. Read More »

Chitosan Performance in the Human Body

Tricol’s chitosan is derived from shrimp shells. Yes! We learned all about this metamorphosis in Article 1 in this series – Chitosan Unleashed!  As you can imagine, there are many complex propriety steps that happen between the extraction of chitosan from shrimp, and the point of using a finished product to control bleeding wounds in Read More »

Chitosan Unleashed!

Chitosan is the active agent in Tricol Biomedical’s HemCon and OneStop hemostasis products and in order to understand how it works, you should first know about chitin. Chitin is the second most abundant naturally occurring biopolymer, after cellulose. In the natural world, chitin functions as scaffold material that gives structure and strength to insect exoskeletons Read More »